Quantinno Capital Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Quantinno Capital Management’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$807K	Buy	+19,383	New	+$794K	﹤0.01%	2350

Other funds holding BBC

KCP

Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MCM

Militia Capital Management Austin, Texas $454M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

APW

Aurora Private Wealth Rockaway, New Jersey $140M AUM

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

GAA

Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Quantinno Capital Management's BBC Position: Q1 2026 in Review

Quantinno Capital Management opened a new position in Virtus Biotech Clinical Trials ETF (BBC) in Q1 2026: 19,383 shares worth $807K. The stake represents ﹤0.01% of the portfolio and ranks #2350 among its holdings.

20 funds tracked by Wall St. Rank hold BBC as of Q1 2026.

Quantinno Capital Management held 19,383 shares of Virtus Biotech Clinical Trials ETF worth $807K as of Q1 2026.
Virtus Biotech Clinical Trials ETF was a new Quantinno Capital Management position in Q1 2026.
Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2350 holding.
20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.